Big Move For ChemoCentryx, Inc.
Thu, Aug 04, 2022 at 07:14 PM
ChemoCentryx, Inc. (CCXI:NASDAQ) shot up at $50.43, a gain of 109.2%. On Thu, Aug 04, 2022, CCXI:NASDAQ touched a New 2-Week High of $50.43. The stock appeared on our News Catalysts scanner on Thu, Aug 04, 2022 at 05:45 PM in the 'ACQUISITION' category. From Thu, Jul 21, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days
About ChemoCentryx, Inc. (CCXI:NASDAQ)
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 109.17%
- Assure Holdings Corp. (IONM:NASDAQ), 103.88%
- Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A) (OG:NYSE), 90.6%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 81%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 75.37%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 65.14%
- Missfresh Limited (MF:NASDAQ), 51.69%
- NanoViricides, Inc. (NNVC:NYSEMKT), 48.37%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 44.37%
- Yellow Corporation (YELL:NASDAQ), 42.25%